ArticleFrontiers in medicine2025
Assessing the risk factors and establishing multivariable prediction models for singleton macrosomia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fetal macrosomia is related to adverse neonatal and maternal health outcomes. Therefore, we aimed to evaluate the risk factors for macrosomia and establish multivariable prediction models to enable early identification, prevention, and mitigation of its adverse outcomes. Methods: This retrospective case-control study included 800 singleton pregnant women who delivered in 2022 at Fujian Maternity and Child Health Hospital and Quanzhou Women and Children's Hospital. They were categorized into the macrosomia [birth weight (BW) ≥ 4,000 g, Results: Maternal height ≥ 165 cm [odds ratio (OR) = 2.303, 95% confidence interval (CI): 1.232-4.305], pre-pregnancy overweight (OR = 2.166, 95% CI: 1.119-4.195), pre-pregnancy obesity (OR = 3.189, 95% CI: 1.020-9.968), excessive gestational weight gain in the second trimester (OR = 2.083, 95% CI: 1.250-3.470), and at least two abnormal blood glucose values in the oral glucose tolerance test (OR = 5.267, 95% CI: 1.814-15.29) were identified as risk factors for macrosomia. Additionally, maternal abdominal circumference (AC) plus fundal length ≥ 140 cm (OR = 6.283, 95% CI: 3.976-9.927), fetal biparietal diameter ≥ 10 cm (OR = 3.373, 95% CI: 1.103-10.31), fetal head circumference ≥ 35 cm (OR = 3.473, 95% CI: 1.334-9.041), and fetal AC ≥ 36 cm at pre-delivery (OR = 23.46, 95% CI: 14.81-37.16) were risk factors for macrosomia. Discussion: The construction of the macrosomia prediction model in singleton fetuses during mid-to-late pregnancy and before delivery showed a strong predictive value. This study identified key high-risk factors for macrosomia during the perinatal period. The macrosomia prediction model developed here is expected to enable early identification of macrosomia, allowing for timely interventions aimed at reducing the risk of adverse perinatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.